and were taking medication for IBD. Participants were expected to wear their devices 8 hours a day and respond to questionnaires a minimum of four times a week. The study began in December 2021 ...

BMS is steadily building a position in IBD through drugs like oral S1P receptor ... Zeposia was approved for ulcerative colitis in May 2021, and the new indication is credited with helping sales ...

Globally, more than six million people are affected by IBD, which presents as Crohn’s ... medicine to the right patient.” In November 2021, Sanofi made a similar – but not its first ...

The analysis included 14,768 patients diagnosed with IBD (from January 1990 to July 2021; 6,144 with ulcerative colitis and 8,624 with Crohn disease) and 120,338 matched individuals without IBD. The ...

A new study suggests that men with inflammatory bowel disease (IBD) may face a significantly higher risk of developing heart disease over time.